Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025 ...Middle East

Semaglutide 1 mg demonstrated statistically significant and superior improvement in maximum walking distance by 13% over placebo in adults with type 2 diabetes and symptomatic PAD1 Based on STRIDE trial data, presented at the American College of Cardiology's (ACC) Annual Scientific...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025 )

Also on site :

• Four dead and two missing after San Antonio drenched with strongest rains in more than a decade
• Iconic Rocker, 60, Makes Bold Statement About Having a 'Friend With Benefits'
• How Acting in a Steve Zahn Film Helped Mackenzie Ziegler Rediscover Her Love of Dance (Exclusive)